Mehta Shivan J, Jensen Christopher D, Quinn Virginia P, Schottinger Joanne E, Zauber Ann G, Meester Reinier, Laiyemo Adeyinka O, Fedewa Stacey, Goodman Michael, Fletcher Robert H, Levin Theodore R, Corley Douglas A, Doubeni Chyke A
Division of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Division of Research, Kaiser Permanente, Oakland, CA, USA.
J Gen Intern Med. 2016 Nov;31(11):1323-1330. doi: 10.1007/s11606-016-3792-1. Epub 2016 Jul 13.
Screening outreach programs using population health management principles offer services uniformly to all eligible persons, but racial/ethnic colorectal cancer (CRC) screening patterns in such programs are not well known.
To examine the association between race/ethnicity and the receipt of CRC screening and timely follow-up of positive results before and after implementation of a screening program.
Retrospective cohort study of screen-eligible individuals at the Kaiser Permanente Northern California community-based integrated healthcare delivery system (2004-2013).
A total of 868,934 screen-eligible individuals 51-74 years of age at cohort entry, which included 662,872 persons in the period before program implementation (2004-2006), 654,633 during the first 3 years after implementation (2007-2009), and 665,268 in the period from 4 to 7 years (2010-2013) after program implementation.
A comprehensive system-wide long-term effort to increase CRC that included leadership alignment, goal-setting, and quality assurance through a PHM approach, using mailed fecal immunochemical testing (FIT) along with offering screening at office visits.
Differences over time and by race/ethnicity in up-to-date CRC screening (overall and by test type) and timely follow-up of a positive screen. Race/ethnicity categories included non-Hispanic white, non-Hispanic black, Hispanic/Latino, Asian/Pacific Islander, Native American, and multiple races.
From 2004 to 2013, age/sex-adjusted CRC screening rates increased in all groups, including 35.2 to 81.1 % among whites and 35.6 to 78.0 % among blacks. Screening rates among Hispanics (33.1 to 78.3 %) and Native Americans (29.4 to 74.5 %) remained lower than those for whites both before and after program implementation. Blacks, who had slightly higher rates before program implementation (adjusted rate ratio [RR] = 1.04, 99 % CI: 1.02-1.05), had lower rates after program implementation (RR for period from 4 to 7 years = 0.97, 99 % CI: 0.96-0.97). There were also substantial improvements in timely follow-up of positive screening results.
In this screening program using core PHM principles, CRC screening increased markedly in all racial/ethnic groups, but disparities persisted for some groups and developed in others, which correlated with levels of adoption of mailed FIT.
运用人群健康管理原则的筛查推广项目会向所有符合条件的人统一提供服务,但此类项目中种族/族裔的结直肠癌(CRC)筛查模式尚不为人所知。
考察种族/族裔与CRC筛查接受情况以及筛查项目实施前后阳性结果的及时后续跟进之间的关联。
对北加利福尼亚凯撒医疗集团基于社区的综合医疗服务体系中符合筛查条件的个体进行回顾性队列研究(2004 - 2013年)。
共有868,934名符合筛查条件的个体,队列入组时年龄在51 - 74岁,其中包括项目实施前(2004 - 2006年)的662,872人、实施后的前3年(2007 - 2009年)的654,633人以及实施后4至7年(2010 - 2013年)的665,268人。
一项全系统范围的长期综合努力,旨在通过人群健康管理(PHM)方法提高CRC筛查率,包括领导层协调、目标设定以及质量保证,采用邮寄粪便免疫化学检测(FIT)并在门诊提供筛查服务。
按时间和种族/族裔划分的最新CRC筛查情况(总体及按检测类型)以及阳性筛查结果的及时后续跟进情况。种族/族裔类别包括非西班牙裔白人、非西班牙裔黑人、西班牙裔/拉丁裔、亚裔/太平洋岛民、美洲原住民以及多种族。
2004年至2013年,所有群体的年龄/性别调整后的CRC筛查率均有所上升,其中白人从35.2%升至81.1%,黑人从35.6%升至78.0%。西班牙裔(从33.1%升至78.3%)和美洲原住民(从29.4%升至74.5%)的筛查率在项目实施前后均低于白人。黑人在项目实施前筛查率略高(调整率比[RR]=1.04,99%置信区间:1.02 - 1.05),但在项目实施后有所下降(4至7年期间的RR = 0.97,99%置信区间:0.96 - 0.97)。阳性筛查结果的及时后续跟进也有显著改善。
在这个运用核心PHM原则的筛查项目中,所有种族/族裔群体的CRC筛查率均显著提高,但部分群体的差距依然存在,其他群体则出现了差距,这与邮寄FIT的采用程度相关。